| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |